Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02134067
Title Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Hospital Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
Washington University School of Medicine Division of Oncology Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from for the field